Manager × security

HealthInvest Partners AB NBIX holdings history

Who else holds this security? →

NEUROCRINE BIOSCIENCES INC · CUSIP 64125C109 · CIK 1381843

This is the oldest quarter open without an account, so changes against the quarter before it are withheld. Log in to see them.
Citable facts

As of Jun 30, 2026, HealthInvest Partners AB reported 72.90K NBIX (shares), valued at $12.29M, or 3.31% of its reported non-derivative portfolio. Filed Jul 24, 2026.

Verify history & sources →
Portfolio weight and quantity history
Reported portfolio weight
3.31%
Shares
72.90K
72,898
Reported value
$12.29M
USD

Shares decreased 18.72%; reported value increased 56.42%, and weight changed +0.77 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.

Left: % · Right: Shares · Independently scaled axes

Exact data and methodology

Axes scale independently; a crossing does not mean equal values. Weight uses each quarter's total reported non-derivative value. Same CUSIP; missing quarters are gaps, not zero. Revised history may include later disclosures.

QuarterWeightQuantitySource
Q2 20263.31%72,898SEC filing ↗Filed Jul 24, 2026
Q1 20262.54%89,685SEC filing ↗Filed May 11, 2026
Q4 20254.29%94,796SEC filing ↗Filed Feb 6, 2026
Q3 20255.67%102,625SEC filing ↗Filed Nov 4, 2025
Q2 20254.75%88,392SEC filing ↗Filed Jul 14, 2025
Q1 20253.71%75,881SEC filing ↗Filed May 5, 2025
Q4 20244.40%67,763SEC filing ↗Filed Feb 4, 2025
Q3 20243.28%60,607SEC filing ↗Filed Nov 12, 2024
Q2 20241.98%23,630SEC filing ↗Filed Aug 14, 2024
Q1 20243.65%43,480SEC filing ↗Filed Apr 25, 2024
Q4 20231.30%12,617SEC filing ↗Filed Jan 30, 2024

History & evidence by quarter

QuarterWeightQuantityValueChange explainedSource
Q4 20231.30%12,617$1.66MThe prior quarter is outside the free window. Log in for the comparison.SEC filing ↗
Filed Jan 30, 2024
Q1 20243.65%43,480$6.00MShares increased 244.61%; reported value increased 260.73%, and weight changed +2.35 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Apr 25, 2024
Q2 20241.98%23,630$3.25MShares decreased 45.65%; reported value decreased 45.75%, and weight changed -1.67 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Aug 14, 2024
Q3 20243.28%60,607$6.98MShares increased 156.48%; reported value increased 114.66%, and weight changed +1.30 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Nov 12, 2024
Q4 20244.40%67,763$9.29MShares increased 11.81%; reported value increased 33.00%, and weight changed +1.12 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Feb 4, 2025
Q1 20253.71%75,881$8.39MShares increased 11.98%; reported value decreased 9.64%, and weight changed -0.69 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed May 5, 2025
Q2 20254.75%88,392$11.11MShares increased 16.49%; reported value increased 32.38%, and weight changed +1.04 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Jul 14, 2025
Q3 20255.67%102,625$1.53MShares increased 16.10%; reported value decreased 86.23%, and weight changed +0.92 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Nov 4, 2025
Q4 20254.29%94,796$13.44MShares decreased 7.63%; reported value increased 779.07%, and weight changed -1.38 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Feb 6, 2026
Q1 20262.54%89,685$7.85MShares decreased 5.39%; reported value decreased 41.58%, and weight changed -1.75 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed May 11, 2026
Q2 20263.31%72,898$12.29MShares decreased 18.72%; reported value increased 56.42%, and weight changed +0.77 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Jul 24, 2026
HealthInvest Partners AB · NEUROCRINE BIOSCIENCES INC

Take these holdings further.

This page includes 11 of 11 reported holdings. Log in to look up the full history beyond 3 years, use advanced screening & filtering, download CSV, and get the complete set through the Akkru API.

  • Download CSV
  • Earlier quarters
  • Advanced screening & filtering
  • API & AI access
Already have an account?

+ New accounts get free API credits to explore data beyond ownership filings.

For AI agents & developers

The initial HTML of this page carries its exact data as script#research-data (JSON): values, units, scope, preview limits and SEC sources. Read it directly, no script or API key needed; script#research-access says what needs an account.

Without an account: the last 3 years, with the row caps stated on the page. A free account opens all history on file on these pages and the CSV of what a page shows. Rows beyond the caps and bulk retrieval go through the authenticated API / MCP.

MCP  https://api.akkrudata.ai/mcp

get_institutional_portfolio
{"cik":"1381843","quarter":"2026Q2","cusip":"64125C109"}

get_institutional_manager_history
{"cik":"1381843","page_size":100}

Connect to MCP with OAuth and follow the returned pagination. Credits and usage limits depend on the account.

MCP endpoint
https://api.akkrudata.ai/mcp
API / MCP documentation
/documents
llms.txt
/llms.txt
Sources, coverage & how to read this data

Figures are as reported to the SEC and merged with later amendments where Akkru could match them. Preview limits apply to what is listed, not to the totals, which come from the complete reported data. Nothing is zero-filled: a missing quarter or month is shown as missing.

13F reports quarter-end long positions in securities traded on US exchanges, filed by managers holding at least $100 million of such securities; it is not the manager's full portfolio, not assets under management, and value changes are not returns. Weights use the reported total value as denominator. Option rows show notional value, not premium or net exposure. Amendments are merged into the quarter when Akkru could match them.